94 results
Page 4 of 5
8-K
EX-99.1
85ju0vw7mh 6d
18 Apr 23
MAIA Biotechnology Announces Excellent
11:39am
8-K
EX-99.1
pkxja24fpmb
11 Apr 23
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
DRS
2mncp
23 Dec 22
Draft registration statement
12:00am
8-K
EX-99.1
o5y pe1py4mvy
9 Nov 22
MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
ayilzgl7 b2
9 Nov 22
MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-10.4
4hfs4dk
21 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
ozytz5361i74u0lsshy
21 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
s2e0377fq 1eg7
21 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.3
dx2hqwi4mb8 3ikgrg
21 Sep 22
Departure of Directors or Certain Officers
4:15pm
10-Q
5pc1z9 2lt
22 Aug 22
Quarterly report
8:44am
8-K
p219nn1v
22 Aug 22
MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:16am
8-K
EX-99.1
sm8vpge2th lf9jyv8x
22 Aug 22
MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:16am
8-K
tj1a5x6yre7
1 Aug 22
MAIA Biotechnology Announces Pricing of Initial Public Offering
4:05pm
8-K
EX-99.1
2tjd9a
1 Aug 22
MAIA Biotechnology Announces Pricing of Initial Public Offering
4:05pm
8-K
EX-99.2
5wm395 x8qz7
1 Aug 22
MAIA Biotechnology Announces Pricing of Initial Public Offering
4:05pm
424B4
6vkluualxi26m
29 Jul 22
Prospectus supplement with pricing info
8:31am
FWP
17l74s
13 Jul 22
Free writing prospectus
9:58pm